Human papillomavirus (HPV) 16 antibodies at diagnosis of HPV-related oropharyngeal cancer and antibody trajectories after treatment

OBJECTIVES: Despite the fact that HPV-driven oropharyngeal cancer (HPV-OPC) has relatively low recurrence rates, intensive post-therapy monitoring remains the standard of care. Post-treatment biomarkers are needed to risk stratify HPV-OPC patients for more individualized surveillance intensity and w...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oral Oncol
Main Authors: Zhang, Yuehan, Waterboer, Tim, Haddad, Robert I., Miles, Brett A., Wentz, Alicia, Gross, Neil D., Fakhry, Carole, Quon, Harry, Lorch, Jochen H., Gourin, Christine G., Clayburgh, Daniel, Misiukiewicz, Krzysztof J., Richmon, Jeremy D., Andersen, Peter E., Posner, Marshall R., D’Souza, Gypsyamber
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5788011/
https://ncbi.nlm.nih.gov/pubmed/28351584
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.oraloncology.2017.02.004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados